Arabic Arabic English English French French German German
dark

Biovica Provides Update on FDA Application Process

Biovica, active in cancer diagnostics, announced that the company’s expected timeline for its updated 510-application to the US Food and Drug Administration has been prolonged due to delay in response from FDA. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

SQI Diagnostics Appoints Andrew Morris as Chief Executive Officer, and Grants Options

Next Post

Dynavax Provides Update on its COVID-19 Collaboration with Valneva

Related Posts
Total
0
Share